tradingkey.logo

Becton Dickinson and Co

BDX
201.740USD
-4.300-2.09%
Handelsschluss 01/23, 16:00ETKurse um 15 Minuten verzögert
57.58BMarktkapitalisierung
34.58KGV TTM

Becton Dickinson and Co

201.740
-4.300-2.09%

mehr Informationen über Becton Dickinson and Co Unternehmen

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Becton Dickinson and Co Informationen

BörsenkürzelBDX
Name des UnternehmensBecton Dickinson and Co
IPO-datumOct 31, 2099
CEOPolen (Thomas E)
Anzahl der mitarbeiter72000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
AddresseOne Becton Drive
StadtFRANKLIN LAKES
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07417-1880
Telefon12018476800
Websitehttps://www.bd.com/
BörsenkürzelBDX
IPO-datumOct 31, 2099
CEOPolen (Thomas E)

Führungskräfte von Becton Dickinson and Co

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-678480.00%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
60.06K
+194.00%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
54.82K
+7798.00%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+3005.00%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+117.00%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+2650.00%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.29K
+148.00%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+1972.00%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
6.06K
+10.00%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.54K
+294.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-678480.00%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
60.06K
+194.00%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
54.82K
+7798.00%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+3005.00%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+117.00%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+2650.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medication Delivery Solutions
4.58B
20.95%
Medication Management Solutions
3.47B
15.91%
Pharmaceutical Systems
2.32B
10.64%
Peripheral Intervention
2.00B
9.14%
Specimen Management
1.87B
8.57%
Andere
7.60B
34.80%
Nach RegionUSD
Name
Umsatz
Anteil
United States
12.79B
58.56%
International
9.05B
41.43%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medication Delivery Solutions
4.58B
20.95%
Medication Management Solutions
3.47B
15.91%
Pharmaceutical Systems
2.32B
10.64%
Peripheral Intervention
2.00B
9.14%
Specimen Management
1.87B
8.57%
Andere
7.60B
34.80%

Aktionärsstatistik

Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.34%
T. Rowe Price Investment Management, Inc.
5.70%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.87%
First Eagle Investment Management, L.L.C.
3.51%
Andere
69.40%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
11.34%
T. Rowe Price Investment Management, Inc.
5.70%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.87%
First Eagle Investment Management, L.L.C.
3.51%
Andere
69.40%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
48.45%
Investment Advisor/Hedge Fund
35.80%
Research Firm
3.09%
Pension Fund
2.40%
Bank and Trust
1.47%
Hedge Fund
1.43%
Sovereign Wealth Fund
1.36%
Individual Investor
0.39%
Insurance Company
0.32%
Andere
5.29%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
2786
268.89M
98.17%
+69.96K
2025Q3
2887
268.83M
99.00%
+3.34M
2025Q2
2905
265.92M
96.81%
+120.40K
2025Q1
2872
266.25M
96.81%
-11.23M
2024Q4
2862
265.61M
95.72%
+1.13M
2024Q3
2775
265.14M
93.34%
+4.39M
2024Q2
2770
259.79M
92.17%
+1.30M
2024Q1
2779
258.85M
91.59%
-5.84M
2023Q4
2763
257.96M
92.19%
-5.24M
2023Q3
2735
263.83M
91.15%
+1.97M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
32.31M
11.34%
+141.20K
+0.44%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
16.23M
5.7%
+54.11K
+0.33%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.77M
5.18%
-380.62K
-2.51%
Sep 30, 2025
State Street Investment Management (US)
13.87M
4.87%
+459.22K
+3.42%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
10.00M
3.51%
+1.21M
+13.74%
Sep 30, 2025
MFS Investment Management
8.29M
2.91%
+603.09K
+7.85%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.83M
2.4%
+107.78K
+1.60%
Sep 30, 2025
Wellington Management Company, LLP
5.23M
1.84%
+5.17M
+9056.29%
Sep 30, 2025
Putnam Investment Management, L.L.C.
5.06M
1.78%
+4.13M
+441.23%
Sep 30, 2025
ClearBridge Investments, LLC
4.39M
1.54%
+588.28K
+15.47%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Medical Devices ETF
4.25%
FPA Global Equity ETF
3.12%
Cullen Enhanced Equity Income ETF
3.1%
American Century Focused Large Cap Value ETF
3.04%
iShares Large Cap Value Active ETF
2.72%
First Eagle Global Equity ETF
2.66%
Franklin ClearBridge Enhanced Income ETF
2.66%
T Rowe Price Capital Appreciation Equity ETF
2.65%
Brandes US Value ETF
2.26%
First Trust Indxx Medical Devices ETF
1.92%
Mehr Anzeigen
iShares U.S. Medical Devices ETF
Anteil4.25%
FPA Global Equity ETF
Anteil3.12%
Cullen Enhanced Equity Income ETF
Anteil3.1%
American Century Focused Large Cap Value ETF
Anteil3.04%
iShares Large Cap Value Active ETF
Anteil2.72%
First Eagle Global Equity ETF
Anteil2.66%
Franklin ClearBridge Enhanced Income ETF
Anteil2.66%
T Rowe Price Capital Appreciation Equity ETF
Anteil2.65%
Brandes US Value ETF
Anteil2.26%
First Trust Indxx Medical Devices ETF
Anteil1.92%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 5.54B USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 06, 2025
BDX.NB Final Cash Dividend of gross USD 1.05 paid on Dec 31, 2025 going ex on Dec 08, 2025
Dec 08, 2025
Dec 31, 2025
Dec 08, 2025
Jul 22, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Sep 30, 2025 going ex on Sep 08, 2025
Sep 08, 2025
Sep 30, 2025
Sep 08, 2025
Apr 29, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Jun 30, 2025 going ex on Jun 09, 2025
Jun 09, 2025
Jun 30, 2025
Jun 09, 2025
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Mehr Anzeigen

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI